Engelhard Arzneimittel GmbH & Co.KG

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 1 drug with upcoming expirations

Activity

Key Events

Jan 8, 2021TrialSinolpan® Pharmacy Non-interventional Study - Quality of Live

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

1 patent group across drugs · Source: FDA Orange Book

DrugExpires

Valcyte2 patentsDec 11, 2027

Regulatory

Regulatory Timeline

19973 events

FDADec 23

Klonopin — KLONOPIN RAPIDLY DISINTEGRATING

Application NDA020813 (NDA)

FDASep 26

Seroquel — SEROQUEL

Application NDA020639 (NDA)

FDAApr 9

Klonopin — KLONOPIN

Application NDA017533 (NDA)

19981 event

FDAApr 30

Xeloda — XELODA

Application NDA020896 (NDA)

19991 event

FDAApr 23

Alli — XENICAL

Application NDA020766 (NDA)

20011 event

FDAMar 29

Valcyte — VALCYTE

Application NDA021304 (NDA)

20072 events

FDAMay 17

Seroquel — SEROQUEL XR

Application NDA022047 (NDA)

FDAFeb 7

Alli — ALLI

Application NDA021887 (NDA)

20091 event

FDAAug 28

Valcyte — VALCYTE

Application NDA022257 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)